Placental characteristics in women with polycystic ovary syndrome

This study was funded by the Child Health Research Program of the University Medical Centre Utrecht. The reference group was included as part of a study that was funded by a fellowship award of the European Society for Paediatric Infectious Diseases (ESPID 2005), The Wilhelmina Children's Hospital Research Fund (grant 2004.02), the Catharijne Stichting, the Dutch Asthma Foundation (grant 3.2.07.001) and the Alexandre Suerman Program (University Medical Center Utrecht). M.P.H.K., M.A.d.W., S.M.V.-V., M.L.H., P.G.J.N. and B.B.v.R. have nothing to disclose. B.C.J.M.F. has received fees and grant support from the following companies (in alphabetic order): Actavis, COGI, Euroscreen, Ferring, Finox, Genovum, Gedeon-Richter, Hartstichting, Merck Serono, NGI (Netherlands Genomic Initiative) Ova-Science, Pantharei Bioscience, PregLem, Roche, UMC Utrecht, Uteron and Watson Laboratories. The authors declare complete independence from funders. TRIAL REGISTRATION NUMBER Clinicaltrials.gov, number NCT00821379. Trial registration date: 8 January 2013. First patient enrolment: 16 January 2013.
Source: Human Reproduction - Category: Reproduction Medicine Authors: Tags: Gynaecology Source Type: research